Pharmaceutical Excipients Market By Product 2021 | IndustryARC
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Pharmaceutical Excipients Market
Pharmaceutical Excipients Market: By Product (Organic, Inorganic); By Functionality (Fillers/Diluents, Lubricants, Disintegrants, Binders, Coating, Glidants, Others); By Geography - (2016-2021)
Report Code : CMR 0597
Updated Date: 14 August, 2017  
17

Copies sold

    Client Rating

  • Report Description
  • Table of Contents
  • Tables And Figures
  • Customization Options
Excipients play an important role in formulating a dosage form. These are the ingredients which along with active pharmaceutical ingredients make up the dosage forms. Excipients act as protective agents, bulking agents and can also be used to improve bioavailability of drugs in some instances. Advent of many industries, mainly pharmaceutical, paved way to the pharmaceutical excipient production. Excipient quality plays a vital role in assuring safety, quality and efficacy of dosage forms. Standardization of excipients usually assure the customers of uniform quality across pharmaceutical products, while manufactures are assured of standardized prices of these excipients. The increased spending on healthcare by developing countries is set to increase the utilization of pharmaceutical excipients. 

Based on the type of pharmaceutical excipient products commercially available, this market is classified as organic and inorganic. Rise in healthcare expenditures, demand for new drug delivery systems along with need for enhanced medications are generating impetuous on pharmaceutical excipients market. Various pharmaceutical excipients are used for different drugs depending up on the complexity of the diseases. Another important trend that drives the growth of this market is extensive research on the excipients that has given a better understanding of their functional benefits, thus their inclusion in the drug formulation has increased.

Pharmaceutical Excipients Market

The pharmaceutical excipients market is scrutinized by segments including product, functionalities and geography. Based on various functionalities which pharmaceutical excipients provide include fillers/diluents, disintegrants, lubricants, binders, coating, glidants and more. The report also comprises of the region wise study of the global market including Americas, Europe, Asia-Pacific and Rest of the World.  Excipients can be considered as an indispensable component of medicinal products and in most of the formulations they are present in greater proportion with regards to active pharmaceutical ingredient, as it forms the bulk of the formulation it is always necessary to select an excipient which satisfies the ideal properties for a particular excipient.

Bidders segment is poised to dominate this market during 2016-2021. However, disintegrants as well as filler/diluents are comprehend to witness prominent CAGR of 7.4% and 6.6% respectively during the same period. The enormous potential for pharmaceutical excipients is also indicated by growing healthcare expenditures, rising income levels and improving health awareness amongst peoples.

Sample Companies Profiled in this Report are:
  • Dow plastic additives,
  • Evonik Industries AG,
  • BASF SE,
  • Ashland Inc,
  • 10+.
1. Pharmaceutical Excipients Market Overview
2. Pharmaceutical Excipients Market Executive Summary
3. Pharmaceutical Excipients Market Landscape
   3.1. Market Share Analysis
   3.2. Competitive analysis
      3.2.1. Product Benchmarking
      3.2.2. Top 5 Financials Analysis 
      3.2.3. End-User Profiling
4. Pharmaceutical Excipients Market Forces
   4.1. Market Drivers
   4.2. Market Constraints
   4.3. Market Challenges
   4.4. Market attractiveness
      4.4.1. Bargaining power of suppliers
      4.4.2. Bargaining power of buyers
      4.4.3. Threat of new entrants
      4.4.4. Threat of substitutes
      4.4.5. Rivalry among the competitors
5. Pharmaceutical Excipients Market - Strategic Analysis
   5.1. Value Chain Analysis
   5.2. Pricing Analysis
   5.3. Opportunity Analysis
   5.4. Supplier & Distributors
   5.5. Market Life Cycle Analysis
   5.6. Regulation Analysis
6. Pharmaceutical Excipients Market - By Product
   6.1. Organic 
   6.2. Inorganic
7. Pharmaceutical Excipients Market –By Functionality
   7.1. Filler/Diluents 
   7.2. Lubricants 
   7.3. Disintegrants 
   7.4. Binders
   7.5. Coating 
   7.6. Glidants
   7.7. Others
8. Pharmaceutical Excipients Market – By Geography
   8.1. Americas
      8.1.1. U.S.
      8.1.2. Canada
      8.1.3. Mexico
      8.1.4. Brazil
      8.1.5. Argentina
      8.1.6. Others
   8.2. Europe
      8.2.1. Germany
      8.2.2. U.K.
      8.2.3. France
      8.2.4. Switzerland
      8.2.5. Italy
      8.2.6. Others
   8.3. APAC
      8.3.1. China
      8.3.2. Japan
      8.3.3. India
      8.3.4. Singapore
      8.3.5. Others
   8.4. RoW
      8.4.1. Middle East
      8.4.2. Africa
9. Pharmaceutical Excipients Market Entropy
   9.1. New product launches
   9.2. M&A’s, collaborations, JVs and partnerships
10. Company Profiles
   10.1. BASF SE
   10.2. THE DOW CHEMICAL COMPANY
   10.3. ASHLAND INC
   10.4. Croda International Plc
   10.5. Evonik Industries AG
   10.6. FMC Corporation
   10.7. ROQUETTE FRÈRES S.A.
   10.8. COLORCON INC
   10.9. LUBRIZOL CORPORATION
   10.10. FUJI CHEMICAL INDUSTRIES CO. LTD.
*More than 10 Companies are profiled in this Research Report*
"*Financials would be provided on a best efforts basis for private companies"
11. Appendix
   11.1. Abbreviations
   11.2. Sources
   11.3. Research methodology
   11.4. Bibliography
   11.5. Compilation of expert insights
   11.6. Disclaimer
LIST OF TABLES:

Table 1: Pharmaceutical Excipients Market Revenue, By Product, 2016-2021 ($Million)
Table 2: Pharmaceutical Excipients Market Revenue, By Functionality, 2016-2021 ($Million)


LIST OF FIGURES:

Figure 1: Pharmaceutical Excipients Market Volume & Revenue, By Years, 2016-2021 ($Million)
Figure 2: Pharmaceutical Excipients Market Revenue, By Region, 2016 and 2021 (%)
Figure 3: Pharmaceutical Excipients Market Share Analysis, By Company 2015 (%)
Figure 4: Earnings Per Share (EPS –Pharmaceutical Excipients), By Company
Figure 5: Pharmaceutical Excipients Published Patents, 2012-2016
Figure 6: Pharmaceutical Excipients Published Patents Share, By Countries, 2012-2016 (%)
Figure 7: Pharmaceutical Excipients Market –Porter’s Five Forces
Figure 8: Pharmaceutical excipients Market Life Cycle, 2016.2021
Figure 9: Organic Chemicals: Pharmaceutical Excipients Market Revenue, 2016-2021 ($Million)
Figure 10: Inorganic Chemicals: Pharmaceutical Excipients Market Revenue, 2016-2021 ($Million)
Figure 11: Pharmaceutical Excipients Market Share, By Functionality, 2016, (%)
Figure 12: Fillers/Diluents: Pharmaceutical Excipients Market Revenue, By Functionality, 2016 - 2021 ($Million)
Figure 13: Lubricants: Pharmaceutical Excipients Market Revenue, By Functionality, 2016 - 2021 ($Million)
Figure 14: Disintegrants: Pharmaceutical Excipients Market Revenue, By Functionality, 2016 - 2021 ($Million)
Figure 15: Binders: Pharmaceutical Excipients Market Revenue, By Functionality, 2016 - 2021 ($Million)
Figure 16: Coatings: Pharmaceutical Excipients Market Revenue, By Functionality, 2016 - 2021 ($Million)
Figure 17: Glidants: Pharmaceutical Excipients Market Revenue, By Functionality, 2016 - 2021 ($Million)
Figure 18: Others: Pharmaceutical Excipients Market Revenue, By Functionality, 2016 - 2021 ($Million)
Figure 19: Global Pharmaceutical Excipients Market Revenue, By Geography, 2016 vs. 2021, ($Million) 
Figure 20: Europe: Pharmaceutical Market Overview, 2000 - 2015 ($ Million)
Figure 21: Pharmaceutical R&d Expenditure in Europe (Euro Million), 1990-2015
Figure 22: Number of New Chemical Or Biological Entities (1996–2015)
Figure 23: Europe Pharmaceutical Excipients Market Revenue, 2016 - 2021 ($Million)
Figure 24: Europe Pharmaceutical Excipients Market Revenue, By Type 2016 - 2021 ($Million)
Figure 25: Europe Pharmaceutical Excipients Market Revenue, By End User 2016 - 2021 ($Million)
Figure 26: Germany: GDP and Population, 2012-2015 ($Trillion, Million)
Figure 27: Germany: GDP – Composition of 2015, By Sector of Origin
Figure 28: Germany: Export and Import Value, 2012-2015 ($Billion)
Figure 29: Germany Pharmaceuticals Industry Overview, 2015 ($ Million)
Figure 30: Germany: Pharmaceutical Excipients Market Revenue, 2016 - 2021 ($Million)
Figure 31: France: GDP and Population, 2012-2015 ($Trillion, Million)
Figure 32: France: GDP – Composition of 2015, By Sector of Origin
Figure 33: France: Export and Import Value, 2012-2015 ($Billion)
Figure 34: France: Pharmaceutical Industry Overview, 2014 ($ Million)
Figure 35: France: Pharmaceutical Excipients Market Revenue, 2016 - 2021 ($Million)
Figure 36: Italy: GDP and Population, 2012-2015 ($Trillion, Million)
Figure 37: Italy: GDP – Composition of 2015, By Sector of Origin
Figure 38: Italy: Export and Import Value, 2012-2015 ($Billion)
Figure 39: Italy: Pharmaceutical Industry Overview, 2014 ($ Million)
Figure 40: Italy: Pharmaceutical Excipients Market Revenue, 2016 - 2021 ($Million)
Figure 41: U.K.: GDP and Population, 2012-2015 ($Trillion, Million)
Figure 42: U.K.: GDP – Composition of 2015, By Sector of Origin
Figure 43: U.K.: Export and Import Value, 2012-2015 ($Billion)
Figure 44: UK: Pharmaceutical Industry Overview, 2014 ($ Million)
Figure 45: U.K.: Pharmaceutical Excipients Market Revenue, 2016 - 2021 ($Million)
Figure 46: Switzerland: Pharmaceutical Industry Overview, 2014 ($ Million)
Figure 47: Switzerland.: Pharmaceutical Excipients Market Revenue, 2016 - 2021 ($Million)
Figure 48: Russia: Pharmaceutical Industry Overview, 2014 ($ Million)
Figure 49: Spain: Pharmaceutical Industry Overview, 2014 ($ Million)
Figure 50: Rest of Europe: Pharmaceutical Excipients Market Revenue, By Type, 2016 - 2021 ($Million)
Figure 51: APAC: Pharmaceutical Excipients Market Revenue, 2016 - 2021 ($Million)
Figure 52: APAC: Pharmaceutical Excipients Market Revenue, By Type, 2016 - 2021 ($Million)
Figure 53: APAC: Pharmaceutical Excipients Market Revenue, By End-User, 2016 - 2021 ($Million)
Figure 54: China: GDP and Population, 2012-2015 ($Trillion, Million)
Figure 55: China: GDP – Composition of 2015, By Sector of Origin
Figure 56: China: Export and Import Value, 2012-2015 ($Billion)
Figure 57: China: Healthcare Expenditure Per Capita, 2011 – 2014, (US $)
Figure 58: China Pharmaceutical Excipients Market Revenue, 2016 - 2021 ($Million)
Figure 59: India: GDP and Population, 2012-2015 ($Trillion, Million)
Figure 60: India: GDP – Composition of 2015, By Sector of Origin
Figure 61: India: Export and Import Value, 2012-2015 ($Billion)
Figure 62: India: Healthcare Expenditure Per Capita, 2011 - 2014, (US $)
Figure 63: India: Pharmaceutical Excipients Market Revenue, 2016 - 2021 ($Million)
Figure 64: Japan: GDP and Population, 2012-2015 ($Trillion, Million)
Figure 65: Japan: GDP – Composition of 2015, By Sector of Origin
Figure 66: Japan: Export and Import Value, 2012-2015 ($Billion)
Figure 67: Japan: Healthcare Expenditure Per Capita, 2011 – 2014, (US $)
Figure 68: Japan Pharmaceutical Excipients Market Revenue, 2016 - 2021 ($Million)
Figure 69: Singapore: Healthcare Expenditure Per Capita, 2011 – 2014, (US $)
Figure 70: Singapore: Pharmaceutical Excipients Market Revenue, 2016 - 2021 ($Million)
Figure 71: Rest of APAC Pharmaceutical Excipients Market Revenue, 2016 - 2021 ($Million)
Figure 72: Americas Yuvraj Market Revenue, 2016-2021 ($Million)
Figure 73: Americas Yuvraj Market Revenue, By Type, 2016-2021 ($Million)
Figure 74: Americas Yuvraj Market Revenue, By End-User, 2016-2021 ($Million)
Figure 75: U.S.: GDP and Population, 2012-2015 ($Trillion, Million)
Figure 76: U.S.: GDP – Composition of 2015, By Sector of Origin
Figure 77: U.S.: Export and Import Value, 2012-2015 ($Trillion)
Figure 78: US: Healthcare Expenditure Per Capita, 2011 – 2014, (US $)
Figure 79: U.S.’S Top Five Sources of Imports and Exports of Pharmaceuticals (2015)
Figure 80: U.S. Pharmaceutical Excipients Market Revenue, 2016 - 2021 ($Million)
Figure 81: Canada: GDP and Population, 2012-2015 ($Trillion, Million)
Figure 82: Canada: GDP – Composition of 2015, By Sector of Origin
Figure 83: Canada: Export and Import Value, 2012-2015 ($Billion)
Figure 84: Canada: Healthcare Expenditure Per Capita, 2011 – 2014, (US $)
Figure 85: Canada Pharmaceutical Excipients Market Revenue, 2016 - 2021 ($Million)
Figure 86: Mexico: GDP and Population, 2012-2015 ($Trillion, Million)
Figure 87: Mexico: GDP – Composition of 2015, By Sector of Origin
Figure 88: Mexico: Export and Import Value, 2012-2015 ($Billion)
Figure 89: Mexico: Healthcare Expenditure Per Capita,2011 – 2014, (US $)
Figure 90: Mexico Pharmaceutical Excipients Market Revenue, 2016 - 2021 ($Million)
Figure 91: Argentina: GDP and Population, 2012-2015 ($Billion, Million)
Figure 92: Argentina: GDP – Composition of 2015, By Sector of Origin
Figure 93: Argentina: Export and Import Value, 2012-2015 ($Billion)
Figure 94: Proportional Mortality: Argentina Vs. Brazil, 2016
Figure 95: Argentina: Healthcare Expenditure Per Capita,2011 – 2014, US $
Figure 96: Brazil: GDP and Population, 2012-2015 ($Trillion, Million)
Figure 97: Brazil: GDP – Composition of 2015, By Sector of Origin
Figure 98: Brazil: Export and Import Value, 2012-2015 ($Billion)
Figure 99: Brazil: Healthcare Expenditure Per Capita, 2011 – 2014, US $
Figure 100: Argentina: Pharmaceutical Excipients Market Revenue, 2016 - 2021 ($Million)
Figure 101: Brazil: Pharmaceutical Excipients Market Revenue, 2016 - 2021 ($Million)
Figure 102: Rest of Americas: Pharmaceutical Excipients Market Revenue, 2016 - 2021 ($Million)
Figure 103: Rest of the World Pharmaceutical Excipients Market Revenue, 2016 - 2021 ($B)
Figure 104: Pharmaceutical Sales by Countries, 2012 vs .2017 ($Billion)
Figure 105: RoW: Pharmaceutical Excipients Market Revenue, By Type, 2016 - 2021 ($Million)
Figure 106: RoW: Pharmaceutical Excipients Market Revenue, By End-User, 2016 - 2021 ($Million)
Figure 107: Middle East Pharmaceutical Excipients Market Revenue, 2016 - 2021 ($Million)
Figure 108: UAE: Healthcare Expenditure Per Capita, US $
Figure 109: South Africa: Healthcare Expenditure Per Capita,2011 – 2014, (US $)
Figure 110: Africa Pharmaceutical Excipients Market Revenue,
Figure 111: BASF SE Net revenue, By Years, 2014-2016 ($Billion) 2016 - 2021 ($Million)
Figure 112: BASF SE Net Sales Share, By Business segments, 2016 (%)
Figure 113: BASF SE Net Sales Share, By Geography, 2016 (%)
Figure 114: The Dow Chemical Company Net Sales, By Years, 2013-2016 ($Billion)
Figure 115: The Dow Chemical Company Net Sales Share, By Business segments, 2016 (%)
Figure 116: The Dow Chemical Company Net Sales Share, By Geography, 2016 (%)
Figure 117: Ashland Inc, Net Sales, By Years, 2014-2016 ($Billion)
Figure 118: Ashland Specialty Ingredients, Net Sales Share, By Product, 2016 (%)
Figure 119: Ashland Specialty Ingredients, Net Sales Share, By Geography, 2016 (%)
Figure 120: Croda International Plc Net Sales, By Years, 2013-2016 ($Billion)
Figure 121: Croda International Plc Net Sales Share, By Business segments, 2016 (%)
Figure 122: Croda International Plc Net Sales Share, By Geography, 2016 (%)
Figure 123: Evonik Industries AG, Net Sales, By Years, 2013-2016 ($Billion)
Figure 124: Evonik Industries AG, Net Sales Share, By Business Segment, 2016 (%)
Figure 125: Evonik Industries AG, Net Sales Share, By Geography, 2016 (%)
Figure 126: FMC Corporation Net revenue, By Years, 2014-2016 ($Billion)
Figure 127: FMC Corporation Net Sales Share, By Business segments, 2016 (%)
Figure 128: FMC Corporation Net Sales Share, By Geography, 2016 (%)
Please select Licence
Single User Licence:
US $4250
Corporate User Licence:
US $6250
Related Reports
0px;">Scroll